Logos Capital is a venture capital and private equity firm that specializes in providing growth capital to technology companies. The firm focuses on investments in the technology sector, particularly in software and tech-enabled services businesses that demonstrate strong growth potential and operational excellence.

Edward Zhong

Graham Walmsley

Giovanni Pennetta

Dr. Arsani William

Logos Capital

Passage Bio

Janux Therapeutics

C4 Therapeutics

Allakos

Alpine Immune Sciences

SomaLogic

Ventyx Biosciences

Verve Therapeutics

Athira Pharma

Centessa Pharmaceuticals

Century Therapeutics

GH Research

Graphite Bio

Immunic Therapeutics

Immunovant

Cullinan Oncology

Dice Therapeutics

Edgewise Therapeutics

Logos Global Management, LP

Metric
Company Name	Logos Capital
Symbol
MSH ID	COM:LOGOSCAPITAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital & Private Equity
Country
Stage
Employee Count	11
Website	logoscapital.com
LinkedIn	logos-capital-management-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2K
Web Traffic Growth	0.06
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:LOGOSCAPITAL

Logos Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue